Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Ella R, et al. Among authors: guleria r. Lancet Infect Dis. 2021 May;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7. Epub 2021 Jan 21. Lancet Infect Dis. 2021. PMID: 33485468 Free PMC article. Clinical Trial.
Respiratory pressures in normal Indian subjects.
Pande JN, Verma SK, Singh SP, Guleria R, Khilnani GC. Pande JN, et al. Among authors: guleria r. Indian J Chest Dis Allied Sci. 1998 Oct-Dec;40(4):251-6. Indian J Chest Dis Allied Sci. 1998. PMID: 10091465 Clinical Trial.
Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study.
Kumar G, Mukherjee A, Sharma RK, Menon GR, Sahu D, Wig N, Panda S, Rao VV, Singh S, Guleria R, Bhargava B; National Clinical Registry for COVID-19 Team. Kumar G, et al. Among authors: guleria r. Indian J Med Res. 2021 May;153(5&6):619-628. doi: 10.4103/ijmr.ijmr_1628_21. Indian J Med Res. 2021. PMID: 34259194 Free PMC article.
Author's response.
Kumar G, Mukherjee A, Sharma RK, Menon GR, Sahu D, Wig N, Panda S, Rao VV, Singh S, Guleria R, Bhargava B. Kumar G, et al. Among authors: guleria r. Indian J Med Res. 2021 Sep 16. doi: 10.4103/0971-5916.324796. Online ahead of print. Indian J Med Res. 2021. PMID: 34528523 Free article. No abstract available.
Author's response.
Kumar G, Mukherjee A, Sharma RK, Menon GR, Sahu D, Wig N, Panda S, Rao VV, Singh S, Guleria R, Bhargava B; National Clinical Registry for COVID Team. Kumar G, et al. Among authors: guleria r. Indian J Med Res. 2021 May;153(5&6):697-698. doi: 10.4103/0971-5916.327496. Indian J Med Res. 2021. PMID: 34643570 Free PMC article. No abstract available.
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Kanungo S, Rai S, Reddy P, Verma S, Singh C, Redkar S, Mohapatra S, Pandey A, Ranganadin P, Gumashta R, Multani M, Mohammad S, Bhatt P, Kumari L, Sapkal G, Gupta N, Abraham P, Panda S, Prasad S, Bhargava B, Ella K, Vadrevu KM; COVAXIN Study Group. Ella R, et al. Lancet. 2021 Dec 11;398(10317):2173-2184. doi: 10.1016/S0140-6736(21)02000-6. Epub 2021 Nov 11. Lancet. 2021. PMID: 34774196 Free PMC article. Clinical Trial.
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
Singh UB, Rophina M, Chaudhry R, Senthivel V, Bala K, Bhoyar RC, Jolly B, Jamshed N, Imran M, Gupta R, Aggarwal P, Divakar MK, Sinha S, Arvinden VR, Bajaj A, Shamnath A, Jain A; COVID CBNAAT CORE GROUP; Scaria V, Sivasubbu S, Guleria R. Singh UB, et al. Among authors: guleria r. J Med Virol. 2022 Apr;94(4):1696-1700. doi: 10.1002/jmv.27461. Epub 2021 Nov 25. J Med Virol. 2022. PMID: 34786733 Free PMC article.
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.
Desai D, Khan AR, Soneja M, Mittal A, Naik S, Kodan P, Mandal A, Maher GT, Kumar R, Agarwal A, Gowda NR, H V, Kumar P, Pandey S, Pandey RM, Kumar A, Ray A, Jorwal P, Nischal N, Choudhary A, Brijwal M, Madan K, Lodha R, Sinha S, Dar L, Wig N, Guleria R. Desai D, et al. Among authors: guleria r. Lancet Infect Dis. 2022 Mar;22(3):349-356. doi: 10.1016/S1473-3099(21)00674-5. Epub 2021 Nov 23. Lancet Infect Dis. 2022. PMID: 34826383 Free PMC article. Clinical Trial.
SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
Malhotra S, Mani K, Lodha R, Bakhshi S, Mathur VP, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A, Ahuja V, Sinha S, Guleria R; COVID Reinfection AIIMS Consortium; Dua A, Ahmad S, Sathiyamoorthy R, Sharma A, Sakya T, Gaur V, Chaudhary S, Sharma S, Madan D, Gupta A, Virmani S, Gupta A, Yadav N, Sachdeva S, Sharma S, Singh S, Pandey A, Singh M, Jhurani D, Sarkar S, Lokade AK, Mohammad A, Pandit S, Dubey R, Singh AK, Gohar N, Soni D, Bhattacharyya A, Rai S, Tummala S, Gupta I, Shukla S. Malhotra S, et al. Among authors: guleria r. JAMA Netw Open. 2022 Jan 4;5(1):e2142210. doi: 10.1001/jamanetworkopen.2021.42210. JAMA Netw Open. 2022. PMID: 34994793 Free PMC article.
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial).
Ghati N, Bhatnagar S, Mahendran M, Thakur A, Prasad K, Kumar D, Dwivedi T, Mani K, Tiwari P, Gupta R, Mohan A, Saxena A, Guleria R, Deepti S. Ghati N, et al. Among authors: guleria r. BMC Infect Dis. 2022 Jul 9;22(1):606. doi: 10.1186/s12879-022-07570-5. BMC Infect Dis. 2022. PMID: 35810307 Free PMC article. Clinical Trial.
506 results